Two HSCI faculty members from Brigham and Women's Hospital have been awarded the 2011 Young Investigator Award from the Society for Biomaterials (SFB). Jeffrey Karp, PhD, and Ali Khademhosseini, PhD, MASc, will receive their awards at the SFB Annual Meeting and Exposition in Orlando, Florida in April 2011. Read more about Two HSCI faculty members receive prestigious award
The Harvard Stem Cell Institute (HSCI) invites applications for seed grants funding. The purpose of this program is to provide early funding for innovative projects in the field of stem cell research including basic, translational and clinical research.
Please note that there was a typographical error in the hard copy submission address listed in the original Seed Grant RFP. Hard copies should please be submitted to:
Harvard Stem Cell Institute Holyoke Center, Suite 727W 1350 Massachusetts Avenue Cambridge, MA 02138
Program Overview: The Harvard Stem Cell Institute (HSCI) Blood Program invites applications for Pilot Grant funding for 2011. The purpose of this funding program is to provide resources for innovative projects by investigators in the field of blood stem cell biology, including basic, translational or clinical research. This funding is for groundbreaking, innovative, high-impact research projects that could fundamentally enhance biomedical research. Current work in the Blood Program focuses on understanding blood stem cell self-renewal at a molecular level, both for manipulating stem cell production and function, as well as understanding abnormalities in cancer stem cells in order to develop novel therapies. Read more about Call for proposals: Blood Program pilot grants
Synthetic RNAs Leading to Real Changes in Reprogramming Strategies
Key limiting factors in the utility and applicability of induced pluripotent stem cells (IPSCs) include the low efficiency of transformation and the potentially oncogenic factors that are used in the protocols. An exciting advance recently published by Harvard Stem Cell Institute Principal Faculty member Derrick Rossi and colleagues is now likely to remove both these obstacles. In their new paper, Rossi and fellow researchers describe a reprogramming strategy that uses synthetic mRNAS to reprogram cells to
The Harvard Stem Cell Institute (HSCI) Kidney Program invites applications for Pilot Grant funding for 2010-2011. The purpose of this funding program is to provide resources for innovative projects by investigators in the field of kidney stem cell biology, including basic, translational or clinical research. This funding is for groundbreaking, innovative, high- impact research projects that could fundamentally enhance biomedical research around proximal tubule associated components of the kidney.
Little could we have imagined that we would be writing to you about yet another governmental impediment to the development of stem cell-based treatments and cures that millions of Americans desperately await.
But sadly, as you know from the latest news reports, the Chief Justice of the U.S. District Court for the District of Columbia has issued a temporary injunction barring the federal government from funding research on any human embryonic stem cell lines - including those approved by
"The American Society of Hematology (ASH), the world’s largest professional society of blood specialists, will honor six scientists who have made significant contributions to the understanding and treatment of hematologic diseases. These awards will be presented at the 52nd ASH Annual Meeting taking place December 4-7 in Orlando."
Two HSCI Principal Faculty members are among those receiving awards.
"David T. Scadden, MD, of the Massachusetts General Hospital and the Harvard Stem Cell Institute, Boston, MA, will be presented with the 2010 Dameshek Prize for his landmark